The glioblastoma market is witnessing rapid advancements driven by ongoing innovation in therapeutic approaches and increased investment in brain cancer research. With aggressive tumor biology and limited treatment efficacy, glioblastoma remains one of the most challenging oncology segments, prompting robust market activity and evolving business growth strategies to improve patient...